HEADER TRANSFERASE 17-AUG-16 5LQE OBSLTE 10-MAY-17 5LQE 5NEV TITLE CDK2/CYCLIN A IN COMPLEX WITH COMPOUND 73 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN-A2; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: CYCLIN-A; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: CCNA2, CCN1, CCNA; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS CDK2 CYCLIN A, CDK2 SELECTIVE TRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.R.COXON,E.ANSCOMBE,S.J.HARNOR,M.P.MARTIN,B.CARBAIN,I.R.HARDCASTLE, AUTHOR 2 L.K.HARLOW,S.KOROLCHUK,C.J.MATHESON,M.E.M.NOBLE,D.R.NEWELL,D.TURNER, AUTHOR 3 M.SIVAPRAKASAM,L.Z.WANG,C.WONG,B.T.GOLDING,R.J.GRIFFIN,G.CANO REVDAT 4 10-MAY-17 5LQE 1 OBSLTE REVDAT 3 22-MAR-17 5LQE 1 JRNL REVDAT 2 22-FEB-17 5LQE 1 JRNL REVDAT 1 11-JAN-17 5LQE 0 JRNL AUTH C.R.COXON,E.ANSCOMBE,S.J.HARNOR,M.P.MARTIN,B.CARBAIN, JRNL AUTH 2 B.T.GOLDING,I.R.HARDCASTLE,L.K.HARLOW,S.KOROLCHUK, JRNL AUTH 3 C.J.MATHESON,D.R.NEWELL,M.E.NOBLE,M.SIVAPRAKASAM, JRNL AUTH 4 S.J.TUDHOPE,D.M.TURNER,L.Z.WANG,S.R.WEDGE,C.WONG, JRNL AUTH 5 R.J.GRIFFIN,J.A.ENDICOTT,C.CANO JRNL TITL CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS: STRUCTURE-ACTIVITY JRNL TITL 2 RELATIONSHIPS AND INSIGHTS INTO THE CDK-2 SELECTIVITY OF JRNL TITL 3 6-SUBSTITUTED 2-ARYLAMINOPURINES. JRNL REF J. MED. CHEM. V. 60 1746 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28005359 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01254 REMARK 2 REMARK 2 RESOLUTION. 2.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 29173 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1544 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.97 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2135 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3420 REMARK 3 BIN FREE R VALUE SET COUNT : 110 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 78.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.56000 REMARK 3 B22 (A**2) : 0.39000 REMARK 3 B33 (A**2) : 3.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.447 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.419 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.995 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9207 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12506 ; 1.770 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1104 ; 5.978 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 393 ;42.638 ;23.969 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1609 ;20.391 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;22.440 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1406 ; 0.115 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6832 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4429 ; 5.076 ; 7.623 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5527 ; 8.238 ;11.418 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4778 ; 5.214 ; 8.120 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 13786 ;21.332 ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 2 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 0 294 C 0 294 18382 0.08 0.05 REMARK 3 2 B 175 431 D 175 431 16616 0.09 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5LQE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1200001199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.969 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30773 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.970 REMARK 200 RESOLUTION RANGE LOW (A) : 66.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1H1S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 5 MG PER ML. 0.6 TO 0.8 M REMARK 280 KCL, 0.9 TO 1.2 M (NH4)2SO4, AND 100 MM HEPES (PH 7.0), VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.76350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.61000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.02650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.61000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.76350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.02650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 LEU A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 MET B 173 REMARK 465 GLU B 174 REMARK 465 LEU B 432 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 MET D 173 REMARK 465 GLU D 174 REMARK 465 LEU D 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR C 15 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP A 68 OH 72L A 301 1.52 REMARK 500 C TYR A 77 C20 72L A 301 1.65 REMARK 500 CA TYR A 77 C21 72L A 301 1.69 REMARK 500 C LEU A 76 C22 72L A 301 1.70 REMARK 500 N LEU A 78 C21 72L A 301 1.72 REMARK 500 N2 72L A 301 N 72L C 301 1.82 REMARK 500 O VAL A 69 CG 72L A 301 1.86 REMARK 500 O VAL A 69 N1 72L A 301 1.92 REMARK 500 CA TYR A 77 C22 72L A 301 1.94 REMARK 500 O VAL A 69 CD2 72L A 301 2.05 REMARK 500 O VAL A 69 CB 72L A 301 2.07 REMARK 500 C VAL A 69 CD2 72L A 301 2.09 REMARK 500 O VAL C 69 O2 72L C 301 2.10 REMARK 500 CG1 VAL A 79 O2 72L A 301 2.12 REMARK 500 CA LEU A 78 C20 72L A 301 2.16 REMARK 500 O LEU A 76 C22 72L A 301 2.18 REMARK 500 CA 72L A 301 N 72L C 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O LYS C 9 NE2 GLN D 403 3455 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 69 CG1 - CB - CG2 ANGL. DEV. = -10.0 DEGREES REMARK 500 LEU A 78 CA - CB - CG ANGL. DEV. = 15.7 DEGREES REMARK 500 LEU C 78 CA - CB - CG ANGL. DEV. = 16.9 DEGREES REMARK 500 LEU C 128 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 LEU C 212 CA - CB - CG ANGL. DEV. = 18.3 DEGREES REMARK 500 LEU D 320 CA - CB - CG ANGL. DEV. = 14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 15 -17.05 89.19 REMARK 500 THR A 41 43.25 -90.03 REMARK 500 ASP A 127 41.56 -155.20 REMARK 500 SER A 181 -144.51 -130.30 REMARK 500 ARG A 199 -2.49 47.87 REMARK 500 THR A 290 -158.27 -124.49 REMARK 500 TYR B 178 -9.94 69.17 REMARK 500 VAL B 367 -66.03 -98.23 REMARK 500 TRP B 372 111.13 -32.44 REMARK 500 LEU B 430 -84.86 -63.20 REMARK 500 GLU C 42 -5.43 75.06 REMARK 500 ASP C 127 -42.98 -140.32 REMARK 500 LEU C 128 64.23 26.28 REMARK 500 VAL C 163 -60.66 -107.06 REMARK 500 SER C 181 -150.23 -127.86 REMARK 500 ARG C 199 14.16 -52.34 REMARK 500 THR C 290 -161.65 -121.79 REMARK 500 VAL D 367 -65.95 -98.20 REMARK 500 TRP D 372 111.20 -33.23 REMARK 500 LEU D 430 170.68 -51.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS C 295 LEU C 296 148.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues 72L A 301 and 72L C REMARK 800 301 DBREF 5LQE A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 5LQE B 174 432 UNP P20248 CCNA2_HUMAN 174 432 DBREF 5LQE C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 5LQE D 174 432 UNP P20248 CCNA2_HUMAN 174 432 SEQADV 5LQE GLY A -4 UNP P24941 EXPRESSION TAG SEQADV 5LQE PRO A -3 UNP P24941 EXPRESSION TAG SEQADV 5LQE LEU A -2 UNP P24941 EXPRESSION TAG SEQADV 5LQE GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 5LQE SER A 0 UNP P24941 EXPRESSION TAG SEQADV 5LQE MET B 173 UNP P20248 INITIATING METHIONINE SEQADV 5LQE GLY C -4 UNP P24941 EXPRESSION TAG SEQADV 5LQE PRO C -3 UNP P24941 EXPRESSION TAG SEQADV 5LQE LEU C -2 UNP P24941 EXPRESSION TAG SEQADV 5LQE GLY C -1 UNP P24941 EXPRESSION TAG SEQADV 5LQE SER C 0 UNP P24941 EXPRESSION TAG SEQADV 5LQE MET D 173 UNP P20248 INITIATING METHIONINE SEQRES 1 A 303 GLY PRO LEU GLY SER MET GLU ASN PHE GLN LYS VAL GLU SEQRES 2 A 303 LYS ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA SEQRES 3 A 303 ARG ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS SEQRES 4 A 303 ILE ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR SEQRES 5 A 303 ALA ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS SEQRES 6 A 303 PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU SEQRES 7 A 303 ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP SEQRES 8 A 303 LEU LYS LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE SEQRES 9 A 303 PRO LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU SEQRES 10 A 303 GLN GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS SEQRES 11 A 303 ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU SEQRES 12 A 303 GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA SEQRES 13 A 303 PHE GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL SEQRES 14 A 303 THR LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS SEQRES 15 A 303 LYS TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY SEQRES 16 A 303 CYS ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE SEQRES 17 A 303 PRO GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE SEQRES 18 A 303 ARG THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY SEQRES 19 A 303 VAL THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS SEQRES 20 A 303 TRP ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU SEQRES 21 A 303 ASP GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS SEQRES 22 A 303 TYR ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU SEQRES 23 A 303 ALA HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO SEQRES 24 A 303 HIS LEU ARG LEU SEQRES 1 B 260 MET GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 B 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 B 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 B 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 B 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 B 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 B 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 B 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 B 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 B 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 B 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 B 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 B 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 B 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 B 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 B 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 B 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 B 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 B 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 B 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 303 GLY PRO LEU GLY SER MET GLU ASN PHE GLN LYS VAL GLU SEQRES 2 C 303 LYS ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA SEQRES 3 C 303 ARG ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS SEQRES 4 C 303 ILE ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR SEQRES 5 C 303 ALA ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS SEQRES 6 C 303 PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU SEQRES 7 C 303 ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP SEQRES 8 C 303 LEU LYS LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE SEQRES 9 C 303 PRO LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU SEQRES 10 C 303 GLN GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS SEQRES 11 C 303 ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU SEQRES 12 C 303 GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA SEQRES 13 C 303 PHE GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL SEQRES 14 C 303 THR LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS SEQRES 15 C 303 LYS TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY SEQRES 16 C 303 CYS ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE SEQRES 17 C 303 PRO GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE SEQRES 18 C 303 ARG THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY SEQRES 19 C 303 VAL THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS SEQRES 20 C 303 TRP ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU SEQRES 21 C 303 ASP GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS SEQRES 22 C 303 TYR ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU SEQRES 23 C 303 ALA HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO SEQRES 24 C 303 HIS LEU ARG LEU SEQRES 1 D 260 MET GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR SEQRES 2 D 260 LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY SEQRES 3 D 260 TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG SEQRES 4 D 260 ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU SEQRES 5 D 260 TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN SEQRES 6 D 260 TYR ILE ASP ARG PHE LEU SER SER MET SER VAL LEU ARG SEQRES 7 D 260 GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU SEQRES 8 D 260 ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA SEQRES 9 D 260 GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS SEQRES 10 D 260 GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU SEQRES 11 D 260 THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU SEQRES 12 D 260 THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS SEQRES 13 D 260 VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU SEQRES 14 D 260 ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL SEQRES 15 D 260 ILE ALA GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL SEQRES 16 D 260 THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR SEQRES 17 D 260 GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP SEQRES 18 D 260 LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN SEQRES 19 D 260 GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS SEQRES 20 D 260 GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU MODRES 5LQE TPO A 160 THR MODIFIED RESIDUE MODRES 5LQE TPO C 160 THR MODIFIED RESIDUE HET TPO A 160 11 HET TPO C 160 11 HET 72L A 301 32 HET 72L C 301 32 HETNAM TPO PHOSPHOTHREONINE HETNAM 72L 4-[[6-(3-PHENYLPHENYL)-7~{H}-PURIN-2- HETNAM 2 72L YL]AMINO]BENZENESULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 72L 2(C23 H18 N6 O2 S) FORMUL 7 HOH *17(H2 O) HELIX 1 AA1 PRO A 45 LEU A 58 1 14 HELIX 2 AA2 LEU A 87 SER A 94 1 8 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 LYS A 129 GLN A 131 5 3 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 ARG A 199 1 18 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 GLY A 229 MET A 233 5 5 HELIX 10 AB1 ASP A 247 VAL A 252 1 6 HELIX 11 AB2 ASP A 256 LEU A 267 1 12 HELIX 12 AB3 SER A 276 LEU A 281 1 6 HELIX 13 AB4 ALA A 282 GLN A 287 5 6 HELIX 14 AB5 TYR B 178 CYS B 193 1 16 HELIX 15 AB6 GLY B 198 GLN B 203 1 6 HELIX 16 AB7 THR B 207 TYR B 225 1 19 HELIX 17 AB8 GLN B 228 MET B 246 1 19 HELIX 18 AB9 LEU B 249 GLU B 269 1 21 HELIX 19 AC1 GLU B 274 ILE B 281 1 8 HELIX 20 AC2 THR B 287 LEU B 302 1 16 HELIX 21 AC3 THR B 310 PHE B 319 1 10 HELIX 22 AC4 LEU B 320 GLN B 322 5 3 HELIX 23 AC5 ASN B 326 SER B 340 1 15 HELIX 24 AC6 ASP B 343 LEU B 348 1 6 HELIX 25 AC7 LEU B 351 THR B 368 1 18 HELIX 26 AC8 PRO B 373 GLY B 381 1 9 HELIX 27 AC9 THR B 383 LYS B 400 1 18 HELIX 28 AD1 GLN B 407 TYR B 413 1 7 HELIX 29 AD2 LYS B 414 HIS B 419 5 6 HELIX 30 AD3 PRO C 45 LEU C 58 1 14 HELIX 31 AD4 LEU C 87 SER C 94 1 8 HELIX 32 AD5 PRO C 100 HIS C 121 1 22 HELIX 33 AD6 LYS C 129 GLN C 131 5 3 HELIX 34 AD7 THR C 165 ARG C 169 5 5 HELIX 35 AD8 ALA C 170 LEU C 175 1 6 HELIX 36 AD9 THR C 182 THR C 198 1 17 HELIX 37 AE1 SER C 207 GLY C 220 1 14 HELIX 38 AE2 GLY C 229 MET C 233 5 5 HELIX 39 AE3 ASP C 247 VAL C 252 1 6 HELIX 40 AE4 ASP C 256 LEU C 267 1 12 HELIX 41 AE5 SER C 276 LEU C 281 1 6 HELIX 42 AE6 ALA C 282 GLN C 287 5 6 HELIX 43 AE7 TYR D 178 CYS D 193 1 16 HELIX 44 AE8 GLY D 198 GLN D 203 1 6 HELIX 45 AE9 THR D 207 TYR D 225 1 19 HELIX 46 AF1 GLN D 228 MET D 246 1 19 HELIX 47 AF2 LEU D 249 GLY D 251 5 3 HELIX 48 AF3 LYS D 252 GLU D 269 1 18 HELIX 49 AF4 GLU D 274 ILE D 281 1 8 HELIX 50 AF5 THR D 287 LEU D 302 1 16 HELIX 51 AF6 THR D 310 PHE D 319 1 10 HELIX 52 AF7 LEU D 320 GLN D 322 5 3 HELIX 53 AF8 ASN D 326 SER D 340 1 15 HELIX 54 AF9 ASP D 343 LEU D 348 1 6 HELIX 55 AG1 LEU D 351 THR D 368 1 18 HELIX 56 AG2 PRO D 373 GLY D 381 1 9 HELIX 57 AG3 THR D 383 LYS D 400 1 18 HELIX 58 AG4 GLN D 407 TYR D 413 1 7 HELIX 59 AG5 LYS D 414 HIS D 419 5 6 SHEET 1 AA1 5 PHE A 4 GLU A 12 0 SHEET 2 AA1 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O LEU A 32 N TYR A 19 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA1 5 LEU A 66 ILE A 70 -1 N ILE A 70 O TYR A 77 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 AA4 5 PHE C 4 GLU C 12 0 SHEET 2 AA4 5 VAL C 17 ASN C 23 -1 O VAL C 18 N ILE C 10 SHEET 3 AA4 5 VAL C 29 ARG C 36 -1 O LEU C 32 N TYR C 19 SHEET 4 AA4 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 AA4 5 LEU C 66 ILE C 70 -1 N ILE C 70 O TYR C 77 SHEET 1 AA5 3 GLN C 85 ASP C 86 0 SHEET 2 AA5 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 AA5 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 AA6 2 VAL C 123 LEU C 124 0 SHEET 2 AA6 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK N TYR A 77 C22 72L A 301 1555 1555 1.44 LINK C TYR A 77 C21 72L A 301 1555 1555 1.63 LINK N LEU A 78 C20 72L A 301 1555 1555 1.47 LINK CB VAL A 79 O2 72L A 301 1555 1555 1.53 LINK C TYR A 159 N TPO A 160 1555 1555 1.34 LINK C TPO A 160 N HIS A 161 1555 1555 1.34 LINK C TYR C 159 N TPO C 160 1555 1555 1.34 LINK C TPO C 160 N HIS C 161 1555 1555 1.34 LINK C 72L A 301 N 72L C 301 1555 1555 1.39 CISPEP 1 VAL A 154 PRO A 155 0 -5.58 CISPEP 2 GLN B 323 PRO B 324 0 -6.70 CISPEP 3 ASP B 345 PRO B 346 0 8.25 CISPEP 4 THR C 14 TYR C 15 0 -13.93 CISPEP 5 VAL C 154 PRO C 155 0 -4.92 CISPEP 6 GLN D 323 PRO D 324 0 -4.83 CISPEP 7 ASP D 345 PRO D 346 0 8.72 SITE 1 AC1 16 LYS A 33 ASP A 68 VAL A 69 ILE A 70 SITE 2 AC1 16 HIS A 71 LEU A 76 TYR A 77 LEU A 78 SITE 3 AC1 16 VAL A 79 PHE B 304 SER C 0 ASP C 68 SITE 4 AC1 16 VAL C 69 ILE C 70 HIS C 71 LYS D 300 CRYST1 73.527 132.053 149.220 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013600 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007573 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006702 0.00000